Astaxanthin and Cancer: The Science Behind Nature's Most Powerful Anticancer Carotenoid
A Peer-Reviewed Clinical Guide for Clinicians and Patients on Astaxanthin's Anticancer Mechanisms, Natural Sources, and Therapeutic Integration
Researched and written by Keith Bishop, Clinical Nutritionist, Cancer Coach, Integrative Cancer Educator, Retired Pharmacist, and Founder of Prevail Over Cancer and the Prevail Protocol.
Key Takeaways
- Astaxanthin (ASX) is a keto-carotenoid derived primarily from the microalga Haematococcus pluvialis and marine seafood, with antioxidant potency up to 100 times greater than vitamin E.
- Peer-reviewed research documents nine distinct anticancer mechanisms, including NF-κB suppression, Nrf2 activation, apoptosis induction, STAT3 inhibition, and anti-metastatic activity.
- Preclinical evidence spans breast, colon, liver, prostate, lung, leukemia, melanoma, gastric, and oral cancers.
- Emerging 2024–2025 research identifies new mechanisms, including modulation of the gut microbiota and targeting of the USP39/β-catenin pathway in hepatocellular ca ...
Author
Keith Bishop
Clinical Nutritionist, Cancer Coach, Retired Pharmacist, Author
Keith Bishop founded Prevail Over Cancer and is a passionate advocate for cancer awareness and research. With a background in pharmacy and clinical nutrition I’m dedicated to providing insightful and empowering information to help clients, survivors, and caregivers navigate their journey. From personal experiences and a commitment to holistic health, Keith aims to inspire and support the cancer community through comprehensive and accessible content.
Join over 8,000 subscribers!
Get access to Keith's Prevail Over Cancer Newsletter with news, blogs, and updates!
Recent Posts
